Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Queensland Health
US Army
US Department of Justice
Federal Trade Commission
Covington
Colorcon
Dow
Baxter
Johnson and Johnson

Generated: August 20, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title:Formulation of diclofenac
Abstract: The present invention relates to methods for producing particles of diclofenac using dry milling processes as well as compositions comprising diclofenac, medicaments produced using diclofenac in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of diclofenac administered by way of said medicaments.
Inventor(s): Dodd; Aaron (Centennial Park, AU), Meiser; Felix (Mount Claremont, AU), Norret; Marck (Darlington, AU), Russell; Adrian (Rivervale, AU), Bosch; H William (Bryn Mawr, PA)
Assignee: iCeutica Pty Ltd. (Philadelphia, PA)
Application Number:14/621,863
Patent Claims: 1. A solid oral unit dose of a pharmaceutical composition containing 18 mg of diclofenac acid, wherein the diclofenac acid has a median particle size, on a volume average basis, of less than 5000 nm and greater than 25 nm, and wherein the unit dose, when tested in vitro by USP Apparatus I (Basket) method of U.S. Pharmacopoeia at 100 rpm at 37.degree. C. in 900 ml of 0.05% sodium lauryl sulfate in citric acid solution buffered to pH 5.75, has a dissolution rate of diclofenac acid such that 94%, by weight, is released by 75 minutes.

2. The unit dose of claim 1, wherein the diclofenac acid has a median particle size, on a volume average basis, of less than 3000 nm and greater than 25 nm.

3. The unit dose of claim 2, wherein the unit dose has a dissolution rate of diclofenac acid such that 94%, by weight, is released by 60 minutes.

4. The unit dose of claim 2, wherein the unit dose has a dissolution rate of diclofenac acid such that 94%, by weight, is released by 45 minutes.

5. The unit dose of claim 2, wherein the unit dose has a dissolution rate of diclofenac acid such that 94%, by weight, is released by 30 minutes.

6. The unit dose of claim 1, wherein the diclofenac acid has a median particle size, on a volume average basis, of less than 2000 nm and greater than 25 nm.

7. The unit dose of claim 6, wherein the unit dose has a dissolution rate of diclofenac acid such that 94%, by weight, is released by 60 minutes.

8. The unit dose of claim 6, wherein the unit dose has a dissolution rate of diclofenac acid such that 94%, by weight, is released by 45 minutes.

9. The unit dose of claim 6, wherein the unit dose has a dissolution rate of diclofenac acid such that 94%, by weight, is released by 30 minutes.

10. The unit dose of claim 1, wherein the diclofenac acid has a median particle size, on a volume average basis, of less than 1900 nm and greater than 25 nm.

11. The unit dose of claim 1, wherein the diclofenac acid has a median particle size, on a volume average basis, of less than 1700 nm and greater than 25 nm.

12. The unit dose of claim 1, wherein the unit dose has a dissolution rate of diclofenac acid such that 94%, by weight, is released by 60 minutes.

13. The unit dose of claim 1, wherein the unit dose has a dissolution rate of diclofenac acid such that 94%, by weight, is released by 45 minutes.

14. The unit dose of claim 1, wherein the unit dose has a dissolution rate of diclofenac acid such that 94%, by weight, is released by 30 minutes.

15. The unit dose of claim 1 wherein a single dose provides perceptible pain relief to a patient suffering from acute pain.

16. A solid oral unit dose of a pharmaceutical composition containing 35 mg of diclofenac acid, wherein the diclofenac acid has a median particle size, on a volume average basis, of less than 5000 nm and greater than 25 nm, and wherein the unit dose, when tested in vitro by USP Apparatus I (Basket) method of U.S. Pharmacopoeia at 100 rpm at 37.degree. C. in 900 ml of 0.05% sodium lauryl sulfate in citric acid solution buffered to pH 5.75, has a dissolution rate of diclofenac acid such that 95%, by weight, is released by 75 minutes.

17. The unit dose of claim 16, wherein the diclofenac acid has a median particle size, on a volume average basis, of less than 3000 nm and greater than 25 nm.

18. The unit dose of claim 17, wherein the unit dose has a dissolution rate of diclofenac acid such that 95%, by weight, is released by 60 minutes.

19. The unit dose of claim 17, wherein the unit dose has a dissolution rate of diclofenac acid such that 95%, by weight, is released by 45 minutes.

20. The unit dose of claim 17, wherein the unit dose has a dissolution rate of diclofenac acid such that 95%, by weight, is released by 30 minutes.

21. The unit dose of claim 16, wherein the diclofenac acid has a median particle size, on a volume average basis, of less than 2000 nm and greater than 25 nm.

22. The unit dose of claim 21, wherein the unit dose has a dissolution rate of diclofenac acid such that 95%, by weight, is released by 60 minutes.

23. The unit dose of claim 21, wherein the unit dose has a dissolution rate of diclofenac acid such that 95%, by weight, is released by 45 minutes.

24. The unit dose of claim 21, wherein the unit dose has a dissolution rate of diclofenac acid such that 95%, by weight, is released by 30 minutes.

25. The unit dose of claim 16, wherein the diclofenac acid has a median particle size, on a volume average basis, of less than 1900 nm and greater than 25 nm.

26. The unit dose of claim 16, wherein the diclofenac acid has a median particle size, on a volume average basis, of less than 1700 nm and greater than 25 nm.

27. The unit dose of claim 16, wherein the unit dose has a dissolution rate of diclofenac acid such that 95%, by weight, is released by 60 minutes.

28. The unit dose of claim 16, wherein the unit dose has a dissolution rate of diclofenac acid such that 95%, by weight, is released by 45 minutes.

29. The unit dose of claim 16, wherein the unit dose has a dissolution rate of diclofenac acid such that 95%, by weight, is released by 30 minutes.

30. The unit dose of claim 16 wherein a single dose provides perceptible pain relief to a patient suffering from acute pain.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Covington
McKinsey
Deloitte
QuintilesIMS
Fuji
Dow
Citi
Cipla
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot